The article explains how the U.S. Food and Drug Administration has approved the use of a drug made by genetically modified goats. The transgenic goats were modified to produce the protein antithrombin in their milk, which is an anticlotting agent. The author mentions that consumers have shown concern about the goats accidentally entering the food supply.
© 2001-2026 Fundación Dialnet · Todos los derechos reservados